Benchmark Electronics (BHE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Fiscal year 2024 revenue was $2.7 billion, down 6% year-over-year, with Semi-Cap and A&D sectors driving growth, while Medical and AC&C lagged.
Q4 2024 revenue was $657 million, flat sequentially and down 5% year-over-year, in line with guidance.
Non-GAAP gross and operating margins expanded for the fourth consecutive year, with Q4 non-GAAP gross margin at 10.4% and operating margin at 5.1%.
Free cash flow for 2024 was $156 million, supported by inventory reduction and marking the 7th consecutive quarter of positive free cash flow.
Management remains focused on operational excellence, cost control, and strategic investments, including a new facility in Penang, Malaysia.
Financial highlights
Q4 GAAP gross margin was 10.3%, non-GAAP gross margin 10.4%; Q4 GAAP operating margin 4.3%, non-GAAP 5.1%.
Q4 GAAP EPS was $0.50; non-GAAP EPS was $0.61, both above guidance.
FY 2024 GAAP and non-GAAP gross margin were 10.2%, up 70 and 60 basis points year-over-year.
FY 2024 GAAP EPS was $1.72; non-GAAP EPS was $2.29.
Cash and restricted cash at year-end was $328 million; Q4 cash conversion cycle improved to 89 days.
Outlook and guidance
Q1 2025 revenue expected between $620–$660 million; non-GAAP gross margin 10–10.2%; non-GAAP operating margin 4.5–4.7%.
Q1 2025 non-GAAP EPS guidance is $0.48–$0.54.
Full-year 2025 CapEx planned at $65–$75 million, with $15–$20 million in Q1, mainly for Penang IV building.
Free cash flow for 2025 expected at $50–$80 million, inclusive of elevated CapEx.
Semi-Cap and A&D sectors expected to lead growth in 2025, with Medical sector anticipating gradual recovery in the second half.
Latest events from Benchmark Electronics
- Margin and cash flow outperformance driven by sector focus, efficiency, and global positioning.BHE
Sidoti September Small-Cap Virtual Conference8 Jul 2026 - Aerospace, defense, and semi-cap drive growth as global investments and margin expansion continue.BHE
Raymond James 2024 TMT & Consumer Conference8 Jul 2026 - Q3 2024 revenue hit $658M with margin gains, strong cash flow, and Q4 guidance up to $680M.BHE
Q3 20248 Jul 2026 - Q1 2026 revenue up 7% to $677M, outlook raised on strong Medical, AC&C, and Semi-Cap growth.BHE
Q1 202630 Apr 2026 - Leadership transition, sector growth, and strong financials position for future expansion.BHE
28th Annual Needham Growth Conference Virtual21 Apr 2026 - Q4 2025 delivered strong revenue and EPS growth, with robust cash flow and a positive 2026 outlook.BHE
Q4 202520 Apr 2026 - Directors, executive pay, auditor ratification, and incentive plan share increase up for vote.BHE
Proxy filing17 Apr 2026 - Annual meeting covers director elections, executive pay, auditor ratification, and equity plan amendment.BHE
Proxy filing17 Apr 2026 - Growth driven by Semi-Cap, AI, and medical sectors, with strong margins and disciplined capital use.BHE
Sidoti March Small-Cap Virtual Conference19 Mar 2026